Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Firebrick Pharma Limited ( (AU:FRE) ) has provided an update.
Firebrick Pharma Limited has announced a change in the interests of a substantial holder, Stephen Francis Goodall and related parties. The change, effective from March 5, 2025, reflects a dilutionary effect due to a private placement, resulting in an adjusted voting power. This development may impact the company’s shareholder structure and influence its governance dynamics.
More about Firebrick Pharma Limited
YTD Price Performance: 53.33%
Average Trading Volume: 178,145
Technical Sentiment Consensus Rating: Sell
Find detailed analytics on FRE stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money